$NEOG

Neogen Corp

Nasdaq · Healthcare · In Vitro & In Vivo Diagnostic Substances · Lansing, MI

NEOG chart

What traders are saying about $NEOG

Latest posts

Neogen Corp news

Neogen Corp key financials

USD2025202420232022
Revenue$870.4M$894.7M$924.2M$822.4M
Net income-$7.9M-$1.09B-$9.4M-$22.9M
Diluted EPS$-0.04$-5.03$-0.04$-0.12
Total assets (year end)$3.36B$4.05B$4.60B$4.56B
Cash and equivalents (year end)$145.3M$140.2M$205.8M$100.0M

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

About Neogen Corp

Ticker
NEOG (Nasdaq)
Industry
In Vitro & In Vivo Diagnostic Substances
Headquarters
Lansing, MI
Incorporated in
MI
Fiscal year end
May 31
SEC CIK
711377

Frequently asked questions

What exchange is Neogen Corp listed on?

Neogen Corp trades on the Nasdaq under the ticker symbol NEOG.

What industry is Neogen Corp in?

Neogen Corp is classified by the SEC under "In Vitro & In Vivo Diagnostic Substances", part of the Healthcare sector on StockTweeting.

Where is Neogen Corp headquartered?

Neogen Corp's business address on file with the SEC is in Lansing, MI.

When does Neogen Corp's fiscal year end?

Neogen Corp's fiscal year ends on May 31.

How much revenue did Neogen Corp report?

Neogen Corp reported $870.4M in revenue for calendar year 2025, according to its SEC filings.